Pfizer Inc
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one that was on the cusp of running out of money. […]
Read More
Goldman’s portfolio of hedge fund favorites is trouncing the market this year. Here’s what’s in it
While the S & P 500 is trading close to its all-time high, a group of favored stocks among hedge funds is soaring even higher, according to Goldman Sachs. The S & P 500 reached an all-time intraday high as well as a new closing record on Wednesday, the broad market index’s second consecutive record […]
Read More
Trump is unlikely to end Medicare drug price talks — here’s what that means for patients and pharma
President Donald Trump arrives in the Brady Press Briefing Room at the White House on Jan. 30, 2025 in Washington, DC. Oliver Contreras | Afp | Getty Images President Donald Trump likely won’t do away with a landmark process that allows Medicare to negotiate drug prices with manufacturers, even as he moves to erase Joe […]
Read More
Bristol Myers’ stock decline in response to weak guidance is a gift to investors
Bristol Myers Squibb on Thursday reported better-than-expected quarterly results, but weak guidance for 2025 sent shares lower. Jim Cramer’s faith in the drugmaker is unshaken. Revenue in the fourth quarter rose 8% year over year to $12.34 billion, well ahead of the $11.57 billion consensus, according to analysts’ estimates compiled by LSEG. Adjusted earnings per […]
Read More
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost savings effort to chart a path toward long-term […]
Read More
Stocks making the biggest moves midday: Ferrari, Spotify, PayPal, Palantir and more
Check out the companies making headlines in midday trading: Palantir Technologies — The software company surged 22% after reporting stronger-than-expected fourth-quarter results . Palantir attributed this earnings and revenue beat to its artificial intelligence platform gaining traction. The stock was on pace for its best day since Feb. 6, 2024, when it gained 30.8%. AMC […]
Read More
Vaccine stocks fall as Senate panel advances RFK Jr.’s nomination for HHS secretary
FILE PHOTO: Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate Health, Education, Labor, and Pensions (HELP) Committee confirmation hearing on Capitol Hill in Washington, U.S., January 30, 2025. Nathan Howard | Reuters Shares of vaccine companies fell on Tuesday after a Senate panel […]
Read More
Stocks making the biggest moves premarket: Pfizer, PepsiCo, Palantir, Merck & more
Check out the companies making headlines before the bell. Pfizer — The pharmaceutical stock added 1.8% on better-than-expected fourth-quarter results . Pfizer reported adjusted earnings of 63 cents per share on $17.76 billion in revenue. Analysts polled by LSEG estimated earnings of 47 cents per share on revenue of $17.36 billion. PepsiCo — Shares of […]
Read More
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024. Andrew Kelly | Reuters Pfizer on Tuesday reported fourth-quarter earnings and revenue that beat estimates as sales of the company’s Covid products topped expectations and its broad cost-cutting efforts took […]
Read More
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. Trade tailspin 2. Tariff tremor U.S. President Donald Trump speaks with members of the media as he departs the White House, in Washington, U.S., Jan. 31, 2025. Carlos Barria | Reuters Trump slapped 25% tariffs on goods from Canada […]
Read More